It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: soficrow
You DO know that Ebola has been in Atlanta since 1976, right?
About 50 African heads of state and government, the African Union chairperson, a range of US and African civil society and business leaders, young African leaders, and Members of Congress will attend the 6 August summit.
originally posted by: Destinyone
originally posted by: WCmutant
a reply to: Destinyone
Not only does Atlanta have direct flights to/from Africa... the CDC is conveniently nearby.
I would worry that these morons are bringing it to America to "study" - or weaponize. The USA has never been exposed to ebola, there is no telling what could happen if it "escapes/spreads" into America's virgin ebola population.
Now that it's out in the news that the U.S. Defense dept is working with the CDC on bringing the 2 ebola patients here, it's to look at ebola for possibly 2 things.
Looking at Ebola as a biological weapon. Or 2, looking at Ebola if it were to be used as a biological weapon.
No matter which, it makes me uncomfortable.
there is work going on, some of it funded by the American military. The US department of defence Joint Project Manager Medical Countermeasure Systems has put $140m (£80m) into the early development of a potential drug by the Tekmira Pharmaceuticals Corporation, which dosed its first human subject in January this year. The phase 1 trial is designed only to ensure the drug has no ill effects in healthy people who have been nowhere near the Ebola virus, but last week, it was put on hold while the regulator, the food and drug administration, asked for more information to ensure the safety of the volunteers.
The DoD is listed as a collaborator in a “First in Human” Ebola clinical trial (NCT02041715, which started in January 2014 shortly before an Ebola epidemic was declared in West Africa.
Disturbingly, the US government has an viral fever bioterrorism research laboratory in Kenema, a town at the epicentre of the Ebola outbreak in West Africa.
There has been speculation as to whether a mysterious 5th cohort added to the Tekmira clinical trial was linked to the outbreak in Guinea.
SIERRA LEONE CLOSES US BIOWEAPONS LAB AT CENTRE OF EBOLA OUTBREAK, STOPS TULANE UNIVERSITY FROM EBOLA TESTING
Ebola virus was isolated from semen 61 days after onset of illness in a man who was infected in a laboratory.
The incubation period, that is, the time interval from infection with the virus to onset of symptoms, is 2 to 21 days.
originally posted by: Blue_Jay33
And I saw, and look! a pale horse, and the one seated on it had the name Death. And the Grave was closely following him. And authority was given them over the fourth part of the earth, to kill with a long sword and with food shortage and with deadly plague and by the wild beasts of the earth.
Ebola is certainly part of the deadly plague predicted here.
Also this scripture in Ezekiel
Plague and bloodshed will sweep through you
Ebola causes you to bleed in it's latter stages
A German firm has applied for the approval of the export of 184 genetic elements with nucleic acid sequences of viruses for the production of recombinant viruses. The viruses will be used in optical imaging to identify host factors required for viral replication. The recipient in the USA is, according to the enclosed end use certificate, the Department of the Army "US Army Medical Research Institute for Infectious Diseases (USAMRIID)" Fort Detrick, Maryland. Specifications in English about the goods, the recipient and end use can be seen from the end use certificate. The goods are controlled by the Australia Group and are subject to compulsory export approval (List position C1C353A). This matter concerns the complete genome of viruses such as the Zaire Ebola virus, the Lake Victoria Marburg virus, the Machupo virus and the Lassa virus, which are absolutely among the most dangerous pathogens in the world. The delivery would place the recipient in the position of being able to create replicating recombinant infectious species of these viruses.